vs
Side-by-side financial comparison of FEDERAL AGRICULTURAL MORTGAGE CORP (AGM) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
FEDERAL AGRICULTURAL MORTGAGE CORP is the larger business by last-quarter revenue ($107.5M vs $85.1M, roughly 1.3× 4D Molecular Therapeutics, Inc.). On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 6.1%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 7.1%).
The Federal Agricultural Mortgage Corporation, also known as Farmer Mac, is a stockholder-owned, federally chartered corporation established by the U.S. Congress in 1988 under the Agricultural Credit Act of 1987. It was created to establish a secondary market for agricultural real estate and housing mortgage loans, to increase liquidity and the availability of long-term, stable credit for farmers, ranchers, and rural communities.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
AGM vs FDMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $107.5M | $85.1M |
| Net Profit | — | $19.4M |
| Gross Margin | — | — |
| Operating Margin | 56.3% | 17.3% |
| Net Margin | — | 22.8% |
| Revenue YoY | 6.1% | 8508900.0% |
| Net Profit YoY | — | 139.1% |
| EPS (diluted) | $3.69 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $107.5M | $85.1M | ||
| Q3 25 | $104.0M | $90.0K | ||
| Q2 25 | $102.6M | $15.0K | ||
| Q1 25 | $94.3M | $14.0K | ||
| Q4 24 | $101.3M | $1.0K | ||
| Q3 24 | $90.3M | $3.0K | ||
| Q2 24 | $89.9M | $5.0K | ||
| Q1 24 | $93.7M | $28.0K |
| Q4 25 | — | $19.4M | ||
| Q3 25 | $55.0M | $-56.9M | ||
| Q2 25 | $54.8M | $-54.7M | ||
| Q1 25 | $49.7M | $-48.0M | ||
| Q4 24 | $56.5M | — | ||
| Q3 24 | $49.8M | $-43.8M | ||
| Q2 24 | $47.1M | $-35.0M | ||
| Q1 24 | $53.7M | $-32.4M |
| Q4 25 | 56.3% | 17.3% | ||
| Q3 25 | 64.1% | -67983.3% | ||
| Q2 25 | 63.8% | -396373.3% | ||
| Q1 25 | 66.9% | -383007.1% | ||
| Q4 24 | 67.5% | — | ||
| Q3 24 | 69.0% | -1704400.0% | ||
| Q2 24 | 65.9% | -849120.0% | ||
| Q1 24 | 72.8% | -136200.0% |
| Q4 25 | — | 22.8% | ||
| Q3 25 | 52.9% | -63195.6% | ||
| Q2 25 | 53.4% | -364386.7% | ||
| Q1 25 | 52.6% | -342657.1% | ||
| Q4 24 | 55.8% | — | ||
| Q3 24 | 55.2% | -1461433.3% | ||
| Q2 24 | 52.4% | -699060.0% | ||
| Q1 24 | 57.4% | -115717.9% |
| Q4 25 | $3.69 | $0.43 | ||
| Q3 25 | $4.44 | $-1.01 | ||
| Q2 25 | $4.48 | $-0.98 | ||
| Q1 25 | $4.01 | $-0.86 | ||
| Q4 24 | $4.62 | — | ||
| Q3 24 | $3.86 | $-0.79 | ||
| Q2 24 | $3.68 | $-0.63 | ||
| Q1 24 | $4.28 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $402.7M |
| Total DebtLower is stronger | $30.8B | — |
| Stockholders' EquityBook value | $1.7B | $505.7M |
| Total Assets | $35.4B | $566.7M |
| Debt / EquityLower = less leverage | 17.93× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $402.7M | ||
| Q3 25 | — | $305.1M | ||
| Q2 25 | — | $293.2M | ||
| Q1 25 | — | $321.4M | ||
| Q4 24 | — | $424.9M | ||
| Q3 24 | $842.1M | $501.9M | ||
| Q2 24 | $923.0M | $541.9M | ||
| Q1 24 | $745.1M | $525.9M |
| Q4 25 | $30.8B | — | ||
| Q3 25 | $29.2B | — | ||
| Q2 25 | $28.9B | — | ||
| Q1 25 | $28.0B | — | ||
| Q4 24 | $27.5B | — | ||
| Q3 24 | $27.2B | — | ||
| Q2 24 | $26.8B | — | ||
| Q1 24 | $26.8B | — |
| Q4 25 | $1.7B | $505.7M | ||
| Q3 25 | $1.7B | $369.0M | ||
| Q2 25 | $1.5B | $420.9M | ||
| Q1 25 | $1.5B | $469.7M | ||
| Q4 24 | $1.5B | $510.6M | ||
| Q3 24 | $1.5B | $552.9M | ||
| Q2 24 | $1.5B | $588.3M | ||
| Q1 24 | $1.5B | $600.6M |
| Q4 25 | $35.4B | $566.7M | ||
| Q3 25 | $33.4B | $424.0M | ||
| Q2 25 | $33.0B | $473.6M | ||
| Q1 25 | $31.8B | $515.7M | ||
| Q4 24 | $31.3B | $560.4M | ||
| Q3 24 | $30.6B | $604.0M | ||
| Q2 24 | $30.2B | $620.1M | ||
| Q1 24 | $29.8B | $629.9M |
| Q4 25 | 17.93× | — | ||
| Q3 25 | 17.31× | — | ||
| Q2 25 | 18.70× | — | ||
| Q1 25 | 18.39× | — | ||
| Q4 24 | 18.48× | — | ||
| Q3 24 | 18.60× | — | ||
| Q2 24 | 17.87× | — | ||
| Q1 24 | 18.11× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $80.1M | $28.6M |
| Free Cash FlowOCF − Capex | — | $28.5M |
| FCF MarginFCF / Revenue | — | 33.5% |
| Capex IntensityCapex / Revenue | 0.0% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.1M | $28.6M | ||
| Q3 25 | $74.2M | $-46.5M | ||
| Q2 25 | $-47.7M | $-43.4M | ||
| Q1 25 | $-49.8M | $-47.8M | ||
| Q4 24 | $612.6M | $-134.6M | ||
| Q3 24 | $-44.4M | $-29.4M | ||
| Q2 24 | $56.1M | $-30.2M | ||
| Q1 24 | $233.3M | $-29.1M |
| Q4 25 | — | $28.5M | ||
| Q3 25 | — | $-46.6M | ||
| Q2 25 | — | $-43.4M | ||
| Q1 25 | — | $-48.4M | ||
| Q4 24 | $607.4M | $-138.4M | ||
| Q3 24 | $-44.4M | $-31.2M | ||
| Q2 24 | $52.6M | $-30.6M | ||
| Q1 24 | $231.7M | $-29.8M |
| Q4 25 | — | 33.5% | ||
| Q3 25 | — | -51765.6% | ||
| Q2 25 | — | -289620.0% | ||
| Q1 25 | — | -345635.7% | ||
| Q4 24 | 599.8% | -13837100.0% | ||
| Q3 24 | -49.2% | -1038966.7% | ||
| Q2 24 | 58.5% | -611840.0% | ||
| Q1 24 | 247.3% | -106421.4% |
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 101.1% | ||
| Q2 25 | 0.0% | 440.0% | ||
| Q1 25 | 0.0% | 4507.1% | ||
| Q4 24 | 5.2% | 378600.0% | ||
| Q3 24 | 0.1% | 59266.7% | ||
| Q2 24 | 4.0% | 6980.0% | ||
| Q1 24 | 1.7% | 2535.7% |
| Q4 25 | — | 1.47× | ||
| Q3 25 | 1.35× | — | ||
| Q2 25 | -0.87× | — | ||
| Q1 25 | -1.00× | — | ||
| Q4 24 | 10.84× | — | ||
| Q3 24 | -0.89× | — | ||
| Q2 24 | 1.19× | — | ||
| Q1 24 | 4.34× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
